Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2024-11-28 | 2024-05-29 |
| Drug Identification Number | 02326132 | 02326132 |
| Brand name | TISSEEL | TISSEEL |
| Common or Proper name | TISSEEL Fibrin Sealant – Lyophilized Kit | TISSEEL Fibrin Sealant – Lyophilized Kit |
| Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
| Ingredients | CALCIUM CHLORIDE THROMBIN APROTININ SEALER PROTEIN | CALCIUM CHLORIDE THROMBIN APROTININ SEALER PROTEIN |
| Strength(s) | 40MCMOL 500UNIT 3000KIU 125MG | 40MCMOL 500UNIT 3000KIU 125MG |
| Dosage form(s) | KIT | KIT |
| Route of administration | TOPICAL TOPICAL | TOPICAL TOPICAL |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 1503153 – TISSEEL Fibrin Sealant – Lyophilized Kit – 4ML | 1503153 – TISSEEL Fibrin Sealant – Lyophilized Kit – 4ML |
| ATC code | B02BC | B02BC |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-05-17 | 2024-05-17 |
| Actual start date | 2024-05-17 | 2024-05-17 |
| Estimated end date | 2024-11-30 | 2024-11-30 |
| Actual end date | 2024-10-25 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Depending on the desired use of the product, Baxter Corporation offers the Fibrin Sealant products. In addition to the Fibrin Sealant options, Baxter also offers other alternative products for hemostasis, sealing or tissue adherence. It is recommended that customers contact their local Baxter Advanced Surgery Representative to discuss their specific clinical needs to determine the best possible alternative for their practice.” | Depending on the desired use of the product, Baxter Corporation offers the Fibrin Sealant products. In addition to the Fibrin Sealant options, Baxter also offers other alternative products for hemostasis, sealing or tissue adherence. It is recommended that customers contact their local Baxter Advanced Surgery Representative to discuss their specific clinical needs to determine the best possible alternative for their practice.” |
| Health Canada comments |